Cytosorbents (CTSO) Change in Cash (2010 - 2026)
Cytosorbents (CTSO) posted Change in Cash of -$1.4 million for Q1 2026, down 11.58% on a QoQ basis from -$1.3 million in Q4 2025, and down 142.92% year-over-year from $3.3 million in Q1 2025.
Cytosorbents (CTSO) Change in Cash (2010 - 2026) Analysis & Trends
Cytosorbents' Change in Cash history runs 17 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- Quarterly Change in Cash fell 142.92% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 324.5% YoY) and the FY2025 annual result came in at -$2.0 million, up 65.94% from the prior year.
- Change in Cash was -$1.4 million for Q1 2026 at Cytosorbents, down from -$1.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $5.6 million in Q4 2023 and bottomed at -$12.9 million in Q2 2022.
- A 5-year average of -$2.8 million and a median of -$2.7 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash plunged 349.73% — and 2023, when it surged 1465.95%.
- Cytosorbents' Change in Cash stood at -$407672.0 in 2022, then jumped by 1465.95% to $5.6 million in 2023, then plunged by 143.17% to -$2.4 million in 2024, then surged by 46.46% to -$1.3 million in 2025, then dropped by 11.58% to -$1.4 million in 2026.
- Business Quant data shows CTSO's Change in Cash at -$1.4 million in Q1 2026, -$1.3 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | -1.29 Mn |
| Sep 30, 2025 | -2.67 Mn |
| Jun 30, 2025 | -1.38 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | -5.52 Mn |
| Dec 31, 2023 | 5.57 Mn |
| Sep 30, 2023 | -4.79 Mn |
| Jun 30, 2023 | -5.90 Mn |
| Mar 31, 2023 | -3.10 Mn |
| Dec 31, 2022 | -407,672.00 |
| Sep 30, 2022 | -7.61 Mn |
| Jun 30, 2022 | -12.86 Mn |
| Mar 31, 2022 | -9.11 Mn |
| Dec 31, 2021 | -7.22 Mn |
| Sep 30, 2021 | -4.57 Mn |
| Jun 30, 2021 | -2.86 Mn |